Zdrowie i gospodarka · 28/02/2001

FDA Classifies B-Type Natriuretic Peptide Test System into Class II with Special Controls

The FDA is classifying the B-type natriuretic peptide test system into class II, requiring a special control guidance document, in response to a petition submitted under the Federal Food, Drug, and Cosmetic Act. This move aims to ensure the safety and effectiveness of the device.